Discounted Cash Flow Rating

Strong Sell

Return on Equity Rating

Neutral

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Upgrade To View Simple Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Exponential Moving Average Rating

Upgrade

Upgrade To Get Access

Upgrade To View Relative Strength Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Standard Deviation Rating

Upgrade

Upgrade To Get Access

Upgrade To View Williams %R Rating

Upgrade

Upgrade To Get Access

Upgrade To View Average Directional Index Rating

Upgrade

Upgrade To Get Access

Upgrade To View Insider Trading Rating

Upgrade

Upgrade To Get Access

Wall Street Data Solutions Rating

Neutral

B

Evolent Health, Inc Class A Common Stock (EVH)

Services-management Services

https://www.evolenthealth.com

Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. The company's two reportable segments: EHS and Clinical Solutions. The Company's EHS segment provides an integrated administrative and clinical platform for health plan administration and value-based business infrastructure and clinical Solutions segment addresses a broad spectrum of clinical needs, with tailored solutions for specialty care management in oncology and cardiology and increasingly the musculoskeletal markets and holistic total cost of care improvement. It generates a majority of its revenue from Clinical Solutions segment.

800 NORTH GLEBE RD, SUITE 500
ARLINGTON, VA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/05/2015

Market Cap

3,195,649,200

Shares Outstanding

114,960,000

Weighted SO

114,959,689

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

AGTI --.--%

CMAX --.--%

CERT --.--%

RCM --.--%

DH --.--%

NRC --.--%

SLP --.--%

PRVA --.--%

CPSI --.--%

Beta

1.5460

Last Div

0.0000

Range

17.98-35.0

Chg

0.2900

Avg Vol

2236954

Mkt Cap

3195649200

Exch

NYSE

Country

US

Phone

571 389 6000

DCF Diff

45.8577

DCF

-18.2477

Div Yield

0.0000

P/S

1.3576

EV Multiple

29.4921

P/FV

2.9906

Div Yield %

0.0000

P/E

-42.3498

PEG

-1.6325

Payout

-0.2742

Current Ratio

1.0778

Quick Ratio

1.0778

Cash Ratio

0.2510

DSO

57.9513

DIO

0.0000

Op Cycle

57.9513

DPO

7.2075

CCC

50.7437

Gross Margin

0.1603

Op Margin

-0.0102

Pretax Margin

-0.0401

Net Margin

-0.0316

Eff Tax Rate

0.2108

ROA

-0.0301

ROE

-0.0698

ROCE

-0.0121

NI/EBT

0.7892

EBT/EBIT

3.9288

EBIT/Rev

-0.0102

Debt Ratio

0.3188

D/E

0.7488

LT Debt/Cap

0.4263

Total Debt/Cap

0.4282

Int Coverage

-0.8938

CF/Debt

0.2233

Equity Multi

2.3486

Rec Turnover

6.2984

Pay Turnover

50.6414

Inv Turnover

0.0000

FA Turnover

27.6269

Asset Turnover

0.9510

OCF/Share

1.5366

FCF/Share

1.3160

Cash/Share

1.2325

OCF/Sales

0.0749

FCF/OCF

0.8564

CF Coverage

0.2233

ST Coverage

28.7344

CapEx Coverage

6.9661

Div&CapEx Cov

3.8561

P/BV

2.9906

P/B

2.9906

P/S

1.3576

P/E

-42.3498

P/FCF

21.1731

P/OCF

17.8838

P/CF

17.8838

PEG

-1.6325

P/S

1.3576

EV Multiple

29.4921

P/FV

2.9906

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 13, 03:19 Dr. Abeer AbouYabis Scholarship for Future Doctors Inspires Aspiring Physicians to Tackle Healthcare Challenges GlobeNewswire Inc. Aug 12, 22:00 Global Technology Spending On Core Administration in Healthcare Market Size To Worth USD 61.5 Billion By 2033 | CAGR Of 5.86% Zacks Investment Research Nov 02, 18:50 Evolent Health (EVH) Surpasses Q3 Earnings and Revenue Estimates Zacks Investment Research Oct 25, 19:30 Celestica (CLS) Beats Q3 Earnings and Revenue Estimates Zacks Investment Research Oct 25, 19:30 Celestica (CLS) Beats Q3 Earnings and Revenue Estimates

Revenue Product Segmentation